UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extracorporeal shockwave lithotripsy (ESWL): a chronology

Journal of endourology, 2007-11, Vol.21 (11), p.1249-1254

2007

Volltextzugriff (PDF)

First Clinical Experience with Extracorporeally Induced Destruction of Kidney Stones by Shock Waves

The Journal of urology, 1982-03, Vol.127 (3), p.417-420

1982

Volltextzugriff (PDF)

Eine Methode zur berührungsfreien Zertrümmerung von Nierensteinen durch Stoßwellen - A method for no-contact destruction of kidney Stones by means of shock waves

Biomedizinische Technik, 2009-07, Vol.22 (7-8), p.164-168

2009

Volltextzugriff (PDF)

First Clinical Experience With Extracorporeally Induced Destruction of Kidney Stones by Shock Waves

The Journal of urology, 2002-05, Vol.167 (5), p.1957-1960

2002

Volltextzugriff (PDF)

First clinical experience with extracorporeally induced destruction of kidney stones by shock waves

The Journal of urology, 2002-02, Vol.167 (2), p.844-847

2002

Volltextzugriff (PDF)

Towards a new EMSE generation: Special Technology Update Issue

Journal of endourology, 2002, Vol.16, p.18-21

2002

Volltextzugriff (PDF)

Extracorporeal shockwave lithotripsy (ESWL). Chronology of the development

Urologe. Ausgabe A, 2007-09, Vol.46 (9), p.1015

2007

Volltextzugriff (PDF)

Extrakorporale Stoßwellenlithotripsie (ESWL): Chronologie einer Entwicklung

Urologe. Ausgabe A, 2007-09, Vol.46 (9), p.1015-1019

2007

Volltextzugriff (PDF)

10 years extracorporeal shockwave lithotripsy--progress in shockwave technology

Biomedizinische Technik, 1990, Vol.35 Suppl 3, p.230

1990

Volltextzugriff (PDF)

10 Jahre Extrakorporale Stoßwellenlithotripsie - Fortschritte in der Stoßwellentechnologie

Biomedizinische Technik, 1990, Vol.35 (s3), p.230-232

1990

Volltextzugriff (PDF)

A method for no-contact destruction of kidney stones by means of shock waves (author's transl)

Biomedizinische Technik, 1977-07, Vol.22 (7-8), p.164

1977

Volltextzugriff (PDF)

Prototyp für die klinische Anwendung der berührungsfreien Nierensteinzertrümmerung durch Stoßwellenimpulse

Biomedizinische Technik, 1980, Vol.25 (s1), p.414-416

1980

Volltextzugriff (PDF)

Technik der extrakorporalen Herzstimulation durch mechanische Reize

Biomedizinische Technik, 1980, Vol.25 (s1), p.349-351

1980

Volltextzugriff (PDF)

Painless extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter

Urologe. Ausgabe A, 1987-01, Vol.26 (1), p.29

1987

Volltextzugriff (PDF)

Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism

Molecular cancer therapeutics, 2020-10, Vol.19 (10), p.2126-2138

2020

Volltextzugriff (PDF)

Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

Cell, 2007-04, Vol.129 (2), p.263-275

2007

Volltextzugriff (PDF)

Extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter with a modified shock wave generator. Initial clinical reports of experiences

Urologe. Ausgabe A, 1987-01, Vol.26 (1), p.33

1987

Volltextzugriff (PDF)

External mechanical cardiac stimulation. Methods and possible application (author's transl)

Zeitschrift für Kardiologie, 1979-09, Vol.68 (8), p.583-589

1979

Volltextzugriff (PDF)

Randomized double‐blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta‐analysis

ESC Heart Failure, 2018-12, Vol.5 (6), p.1023-1034

2018

Volltextzugriff (PDF)

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

European journal of endocrinology, 2007-01, Vol.156 (1), p.75-82

2007

Volltextzugriff (PDF)

The allergy‐associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY‐CCL11

Allergy (Copenhagen), 2007-01, Vol.62 (1), p.17-24

2007

Volltextzugriff (PDF)

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

Cancer discovery, 2022-05, Vol.12 (5), p.1248-1265

2022

Volltextzugriff (PDF)

1072TiP Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAM×4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumors

Annals of oncology, 2024-09, Vol.35, p.S709-S710

2024

Volltextzugriff (PDF)

Angiotensin II Receptor–Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179

Circulation research, 2002-04, Vol.90 (7), p.770-776

2002

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(74)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(42)
Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Animals
(21)
Female
(16)
Amino Acid Sequence
(14)
Male
(14)
Molecular Sequence Data
(14)
Biological And Medical Sciences
(13)
Adult
(11)
Medical Sciences
(11)
Biochemistry & Molecular Biology
(10)
Middle Aged
(10)
Cell Biology
(8)
Peptide Fragments - Pharmacology
(7)
Atrial Natriuretic Factor - Therapeutic Use
(6)
Mice
(6)
Peptide Fragments - Chemistry
(6)
Peptide Fragments - Therapeutic Use
(6)
Cardiac & Cardiovascular Systems
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Extracorporeal shockwave lithotripsy (ESWL): a chronology

First Clinical Experience with Extracorporeally Induced Destruction of Kidney Stones by Shock Waves

Eine Methode zur berührungsfreien Zertrümmerung von Nierensteinen durch Stoßwellen - A method for no-contact destruction of kidney Stones by means of shock waves

First Clinical Experience With Extracorporeally Induced Destruction of Kidney Stones by Shock Waves

First clinical experience with extracorporeally induced destruction of kidney stones by shock waves

Towards a new EMSE generation: Special Technology Update Issue

Extracorporeal shockwave lithotripsy (ESWL). Chronology of the development

Extrakorporale Stoßwellenlithotripsie (ESWL): Chronologie einer Entwicklung

10 years extracorporeal shockwave lithotripsy--progress in shockwave technology

10 Jahre Extrakorporale Stoßwellenlithotripsie - Fortschritte in der Stoßwellentechnologie

A method for no-contact destruction of kidney stones by means of shock waves (author's transl)

Prototyp für die klinische Anwendung der berührungsfreien Nierensteinzertrümmerung durch Stoßwellenimpulse

Technik der extrakorporalen Herzstimulation durch mechanische Reize

Painless extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter

Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism

Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

Extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter with a modified shock wave generator. Initial clinical reports of experiences

External mechanical cardiac stimulation. Methods and possible application (author's transl)

Randomized double‐blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta‐analysis

Discovery and Characterization of an Endogenous CXCR4 Antagonist

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

The allergy‐associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY‐CCL11

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

1072TiP Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAM×4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumors

Angiotensin II Receptor–Independent Antiinflammatory and Antiaggregatory Properties of Losartan: Role of the Active Metabolite EXP3179

Suchergebnisse filtern